Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Alpine Immune Sciences Inc (ALPN)

Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,456,812
  • Shares Outstanding, K 68,598
  • Annual Sales, $ 58,880 K
  • Annual Income, $ -32,180 K
  • EBIT $ -51 M
  • EBITDA $ -59 M
  • 60-Month Beta 0.97
  • Price/Sales 75.69
  • Price/Cash Flow N/A
  • Price/Book 12.80
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.64
  • Most Recent Earnings $-0.28 on 05/09/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.42
  • Number of Estimates 5
  • High Estimate -0.30
  • Low Estimate -0.50
  • Prior Year -0.27
  • Growth Rate Est. (year over year) -55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.40 +0.89%
on 04/19/24
65.00 -0.05%
on 05/17/24
+0.51 (+0.79%)
since 04/17/24
3-Month
29.56 +119.79%
on 02/21/24
65.00 -0.05%
on 05/17/24
+33.71 (+107.84%)
since 02/16/24
52-Week
8.33 +679.95%
on 10/26/23
65.00 -0.05%
on 05/17/24
+56.39 (+657.23%)
since 05/17/23

Most Recent Stories

More News
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?

Vertex is broadening its portfolio.

CRSP : 51.37 (+1.20%)
VRTX : 469.47 (-0.35%)
ALPN : 64.97 (+0.02%)
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now

These stocks could be near major inflection points.

ALPN : 64.97 (+0.02%)
BRK.AX : 0.440 (+1.15%)
XOM : 118.23 (+2.85%)
OXY : 50.54 (+1.96%)
PATH : 12.44 (-1.03%)
VRTX : 469.47 (-0.35%)
3 Relatively Safe Growth Stocks You Can Buy and Hold

Low risk and high-reward potential? These stocks could offer both.

ALPN : 64.97 (+0.02%)
LLY : 806.60 (-1.51%)
NVO : 109.79 (-1.92%)
VRTX : 469.47 (-0.35%)
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?

The biotech just added another potential growth driver to its pipeline.

VRTX : 469.47 (-0.35%)
ALPN : 64.97 (+0.02%)
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock

Vertex just laid claim to an asset that might be very valuable.

VRTX : 469.47 (-0.35%)
ALPN : 64.97 (+0.02%)
Could This Stock Be the Next Biotech Buyout?

Vertex Pharmaceuticals' $4.9 billion purchase of Alpine Immune Sciences probably won't be the last acquisition of a company focused on kidney disease.

ALPN : 64.97 (+0.02%)
VRTX : 469.47 (-0.35%)
VERA : 46.24 (+5.52%)
Technology Stocks Power the Broader Market Higher

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.65%. Stock indexes...

$SPX : 5,723.80 (-0.09%)
SPY : 570.39 (-0.11%)
$DOWI : 41,842.21 (-0.50%)
DIA : 418.37 (-0.49%)
$IUXX : 20,026.55 (-0.03%)
QQQ : 487.04 (-0.08%)
ZNZ24 : 110-135 (+0.36%)
PARA : 10.87 (-1.00%)
AAPL : 222.57 (-0.15%)
TEAM : 220.24 (-1.83%)
NVDA : 137.67 (+1.68%)
AVGO : 169.91 (+0.59%)
Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise, Thursday, 4/11/2024

Stocks that traded heavily or had substantial price changes on Thursday: Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise

ALPN : 64.97 (+0.02%)
CONN : 0.0975 (-46.40%)
NTIC : 12.68 (-1.32%)
BTUUQ : 1.1924 (+211.33%)
BTU : 26.84 (+1.36%)
NVS : 110.57 (+1.12%)
KMX : 72.92 (+0.86%)
FAST : 77.70 (-0.68%)
Stock Indexes Rise in Afternoon Trade

The S&P 500 Index ($SPX ) (SPY ) is up +0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.26%. Stock indexes are higher even as bond...

$SPX : 5,723.80 (-0.09%)
SPY : 570.39 (-0.11%)
$DOWI : 41,842.21 (-0.50%)
DIA : 418.37 (-0.49%)
$IUXX : 20,026.55 (-0.03%)
QQQ : 487.04 (-0.08%)
ZNZ24 : 110-135 (+0.36%)
GL : 103.62 (-0.38%)
KMX : 72.92 (+0.86%)
FAST : 77.70 (-0.68%)
GEN : 28.35 (+0.28%)
KVUE : 23.19 (+2.02%)
Stocks Slightly Higher as US Mar PPI Climbs Less Than Expected

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.36%. Stock indexes this morning...

$SPX : 5,723.80 (-0.09%)
SPY : 570.39 (-0.11%)
$DOWI : 41,842.21 (-0.50%)
DIA : 418.37 (-0.49%)
$IUXX : 20,026.55 (-0.03%)
QQQ : 487.04 (-0.08%)
ZNZ24 : 110-135 (+0.36%)
TEAM : 220.24 (-1.83%)
STZ : 241.11 (+3.58%)
AZN : 71.40 (-0.03%)
NVDA : 137.67 (+1.68%)
ALPN : 64.97 (+0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Alpine Immune Sciences Inc. operates as a specialty pharmaceutical company. It engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders and other diseases. Alpine Immune Sciences Inc., formerly known as Nivalis Therapeutics, is based...

See More

Key Turning Points

3rd Resistance Point 65.02
2nd Resistance Point 65.01
1st Resistance Point 64.99
Last Price 64.97
1st Support Level 64.96
2nd Support Level 64.95
3rd Support Level 64.93

See More

52-Week High 65.00
Last Price 64.97
Fibonacci 61.8% 43.35
Fibonacci 50% 36.67
Fibonacci 38.2% 29.98
52-Week Low 8.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar